Inventor · disambiguated record
Akseli Hemminki
Also filed as: HEMMINKI AKSELI
6 granted patents·11 pending applications·44 citations·filing 2009–2022
79Inventor score
Top patents by PatentIndex Score
17 records- 0189US9410129B2Recombinant serotype 5 (Ad5) adenoviral vectorsTARGOVAX OY·Filed 2012·Granted Aug 9, 2016·28 cites·29 claims
- 0284US10647963B2Enhanced adoptive cell therapyTILT BIOTHERAPEUTICS OY·Filed 2014·Granted May 12, 2020·8 cites·24 claims
- 0382US9345787B2Adenoviral vectors and methods and uses related theretoHEMMINKI AKSELI·Filed 2009·Granted May 24, 2016·8 cites·1 claims
- 0460US12421502B2Enhanced adoptive cell therapyTILT BIOTHERAPEUTICS OY·Filed 2020·Granted Sep 23, 2025·0 cites·1 claims
- 0560US2015202324A1Adenoviral vectors and methods and uses related theretoONCOS THERAPEUTICS·Filed 2014·Application pending·0 cites
- 0656US2023272108A1Oncolytic adenoviruses coding for bi-specific antibodies and methods and uses related theretoTILT BIOTHERAPEUTICS OY·Filed 2022·Application pending·0 cites
- 0755US2024398986A1An oncolytic virus vector coding for interleukin-7 (IL-7) polypeptideTILT BIOTHERAPEUTICS OY·Filed 2022·Application pending·0 cites
- 0854US10787645B2Enhanced adoptive cell therapyTILT BIOTHERAPEUTICS OY·Filed 2016·Granted Sep 29, 2020·0 cites·11 claims
- 0952US2024102047A1An oncolytic virus vector coding for variant interleukin-2 (vIL-2) polypeptideTILT BIOTHERAPEUTICS OY·Filed 2020·Application pending·0 cites
- 1051US2022251604A1Oncolytic adenovirus and checkpoint inhibitor combination therapyTILT BIOTHERAPEUTICS OY·Filed 2020·Application pending·0 cites
- 1149US2016208287A1Adenoviral vectors and methods and uses related theretoTARGOVAX OY·Filed 2016·Application pending·0 cites
- 1249US2021038659A1Combination therapy using a chimeric antigen receptorNOVARTIS AG·Filed 2019·Application pending·0 cites
- 1341US2016082100A1RECOMBINANT SEROTYPE 5 (Ad5) ADENOVIRAL VECTORSONCOS THERAPEUTICS OY·Filed 2015·Application pending·0 cites
- 1440US11485791B2Oncolytic adenoviruses coding for bi-specific antibodiesTILT BIOTHERAPEUTICS OY·Filed 2016·Granted Nov 1, 2022·0 cites·6 claims
- 1534US2013323205A1Oncolytic adenoviral vectors and methods and uses related theretoDIACONU IULIA·Filed 2011·Application pending·0 cites
- 1633US2013243731A1Oncolytic adenoviral vectors coding for monoclonal anti-ctla-4 antibodiesDIAS JOAO·Filed 2011·Application pending·0 cites
- 1730US2012063995A1Non-ad5 adenoviral vectors and methods and uses related theretoHEMMINKI OTTO·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Akseli Hemminki files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →